Similar results to those in TM have been obtained with deferiprone in patients with myelodysplasia, myelofibrois, and other acquired marrow diseases. Although there has been theoretical concern that agranulocytosis may be more frequent in these acquired bone marrow disorders than in TM, there are no date to suggest this.